Almasio P - Search Results

1

Duration of HCV infection as a predictor of nonresponse to interferon.

Craxì A, Di Marco V, Cammà C, Almasio P, Magrin S. Craxì A, et al. Among authors: almasio p. Dig Dis Sci. 1996 Dec;41(12 Suppl):86S-92S. doi: 10.1007/BF02087881. Dig Dis Sci. 1996. PMID: 9011482

2

Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial.

Di Marco V, Almasio PL, Ferraro D, Calvaruso V, Alaimo G, Peralta S, Di Stefano R, Craxì A. Di Marco V, et al. J Hepatol. 2007 Oct;47(4):484-91. doi: 10.1016/j.jhep.2007.04.020. Epub 2007 Jun 27. J Hepatol. 2007. PMID: 17692985 Clinical Trial.

3

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C.

Di Marco V, Lo Iacono O, Cammà C, Almasio PL, Vaccaro A, Fuschi P, Giunta M, Fabiano C, Pagliaro L, Craxì A. Di Marco V, et al. Among authors: almasio pl. J Med Virol. 1997 Jan;51(1):17-24. doi: 10.1002/(sici)1096-9071(199701)51:1<17::aid-jmv3>3.0.co;2-v. J Med Virol. 1997. PMID: 8986944 Clinical Trial.

4

Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon.

Almasio PL, Di Marco V, Bonura C, Fuschi P, Camma C, Lo Iacono O, Artini M, Natoli C, Di Stefano R, Levrero M, Craxi A. Almasio PL, et al. Dig Dis Sci. 1999 May;44(5):1013-9. doi: 10.1023/a:1026625001168. Dig Dis Sci. 1999. PMID: 10235612 Clinical Trial.

5

High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.

Di Marco V, Vaccaro A, Ferraro D, Alaimo G, Rodolico V, Parisi P, Peralta S, Di Stefano R, Almasio PL, Craxì A. Di Marco V, et al. Among authors: almasio pl. Aliment Pharmacol Ther. 2001 Jul;15(7):953-8. doi: 10.1046/j.1365-2036.2001.01005.x. Aliment Pharmacol Ther. 2001. PMID: 11421869 Clinical Trial.

6

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

Ferraro D, Bonura C, Giglio M, Di Stefano R, Almasio PL, Di Marco V, Craxì A, Cacciola I, Squadrito G, Raimondo G. Ferraro D, et al. Among authors: almasio pl. J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5. J Biol Regul Homeost Agents. 2003. PMID: 14518718 Clinical Trial.

7

Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.

Venezia G, Licata A, Di Marco V, Craxì A, Almasio PL. Venezia G, et al. Among authors: almasio pl. Dig Liver Dis. 2005 Nov;37(11):882-5. doi: 10.1016/j.dld.2005.06.010. Epub 2005 Sep 15. Dig Liver Dis. 2005. PMID: 16169301

8

Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.

Magrin S, Craxì A, Fabiano C, Fiorentino G, Marino L, Almasio P, Pinzello GB, Palazzo U, Vitale M, Maggio A, et al. Magrin S, et al. Among authors: almasio p. J Med Virol. 1992 Nov;38(3):200-6. doi: 10.1002/jmv.1890380309. J Med Virol. 1992. PMID: 1283753

9

Hepatitis C virus antibodies in chronic liver diseases of different aetiology.

Craxi A, Almasio P, Di Marco V, Magrin S, Bruno R, Cammà C, Fiorentino G, Lo Jacono O, Marino L, Palazzo U, et al. Craxi A, et al. Among authors: almasio p. Ital J Gastroenterol. 1991 Jun;23(5):244-8. Ital J Gastroenterol. 1991. PMID: 1742513

10

Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia.

Almasio P, Mirto S, Malleo C, Di Marco V, Caronia F, Craxi A. Almasio P, et al. Haematologica. 1991 Sep-Oct;76(5):429-30. Haematologica. 1991. PMID: 1806450 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters